Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

NeoGenomics, Inc. (NASDAQ:NEO) Stock Climbs to 52-Week High on Raised Guidance and NGS Growth

Headquartered in Fort Myers, Florida, NeoGenomics is a genetic testing and precision medicine company providing testing services for oncology, reproductive health, and other indications. The company's offerings span cancer genetic testing, prenatal screening, and pharmacogenomics, with a growing focus on next-generation sequencing panels and …

Nitish Kishor | 26 August 2026

Natera, Inc. (NASDAQ:NTRA) Stock Hits 52-Week High as Genetic Testing Volumes Hit Record Levels

Headquartered in Belmont, California, Natera develops and commercializes genetic testing products including PANORAMA, a non-invasive prenatal screening test for chromosomal abnormalities, SIGNATURE, an oncology test for cancer recurrence monitoring, and Horizon, a carrier screening product. The company serves healthcare providers, hospitals, and patients globally, …

Nitish Kishor | 26 August 2026

Precigen, Inc. (NASDAQ:PGEN) Stock Rockets to 52-Week High on Papzimeos Commercial Launch Profitability

Precigen is a biotechnology company focused on developing engineered living medicines using its proprietary platform, which enables the engineering of bacteria and other microorganisms to deliver therapeutic payloads directly to disease sites. The company's pipeline spans oncology, autoimmune diseases, and other serious conditions, with …

Nitish Kishor | 26 August 2026

Hinge Health, Inc. (NYSE:HNGE) Stock Hits 52-Week High as Digital MSK Platform Scales Post-IPO

Headquartered in San Francisco, California, Hinge Health provides comprehensive digital musculoskeletal care solutions including virtual physical therapy, pain management, behavioral health support, and care navigation. The platform combines wearable sensors, a mobile app, and access to health coaches and physical therapists to deliver personalized …

Nitish Kishor | 26 August 2026

Illumina, Inc. (NASDAQ:ILMN) Stock Hits 52-Week High on Strong NovaSeq X Sequencer Placements

Headquartered in San Diego, California, Illumina develops, manufactures, and markets life science tools and integrated systems for large-scale genetic analysis. The company's flagship NovaSeq X system is described as the world's most powerful DNA sequencer, enabling large-scale genomic research and clinical applications, though Illumina …

Nitish Kishor | 26 August 2026

IQVIA Holdings Inc. (NYSE:IQV) Stock Rallies to 52-Week High on Accelerating AI-Driven Analytics Growth

Headquartered in Durham, North Carolina, IQVIA Holdings provides advanced analytics, technology solutions, and clinical research services to the life sciences industry. Formed through the 2016Mergerof IMS Health and Quintiles, the company operates through Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales …

Nitish Kishor | 26 August 2026

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Soars to 52-Week High on Dramatic EBITDA Turnaround

Maravai LifeSciences operates through two primary businesses: TriLink, which provides mRNA discovery reagents and biologics safety testing, and Cygnus, which offers biologics safety testing services. The company serves biopharmaceutical customers developing mRNA-based therapeutics and other biologic products, positioning it within the broader genomics and …

Nitish Kishor | 26 August 2026

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Climbs to 52-Week High on T-Cell Engager Pipeline Progress

Cullinan Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted therapies for cancer. The company's pipeline centers on T cell engagers CLN-978 and CLN-049, alongside a licensed velinotamig program from Genrix and a continued collaboration with Taiho on zipalertinib, leveraging …

Nitish Kishor | 26 August 2026

Quest Diagnostics Incorporated (NYSE:DGX) Stock Hits 52-Week High on New Roche Alzheimer's Testing Deal

Headquartered in Secaucus, New Jersey, Quest Diagnostics operates one of the largest networks of clinical laboratories in the United States, providing testing services to physicians, hospitals, employers, health plans, and patients. The company's offerings span routine blood tests, esoteric and genetic testing, occupational health …

Nitish Kishor | 26 August 2026

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Surges to 52-Week High on Record ENHANZE Royalty Revenue

Headquartered in San Jose, California, Halozyme Therapeutics is a biotechnology company focused on enabling subcutaneous delivery ofBiologicsthrough its proprietary ENHANZE drug delivery technology. The platform uses recombinant human hyaluronidase to temporarily break down hyaluronan in subcutaneous tissue, allowing large volumes of drugs to be …

Nitish Kishor | 26 August 2026
Support

Hi! How can we help you today?

Loading…